Manus Neurodynamica Completes £1.2m Funding Round

Par Portfolio Company, Manus Neurodynamica recently closed a £1.2m funding round to support the launch of its digital pen, which detects early indicators of Parkinson’s disease. 

To date, the company has secured £5 million in funding, including a £750,000 financing round in May last year, led by Par Equity. Investors in this round include the North East Innovation Fund, SIS Ventures and Old College Capital.